145 related articles for article (PubMed ID: 21190299)
41. Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis.
Gan PY; Chan A; Ooi JD; Dick J; Nagai K; O'Sullivan KM; Oudin V; Shim R; Kitching AR; Holdsworth SR
Kidney Int; 2019 Nov; 96(5):1121-1133. PubMed ID: 31443998
[TBL] [Abstract][Full Text] [Related]
42. Pathological role of Toll-like receptor signaling in cerebral malaria.
Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S
Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446
[TBL] [Abstract][Full Text] [Related]
43. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
44. Protein level expression of Toll-like receptors 2, 4 and 9 in renal disease.
Batsford S; Duermueller U; Seemayer C; Mueller C; Hopfer H; Mihatsch M
Nephrol Dial Transplant; 2011 Apr; 26(4):1413-6. PubMed ID: 21220755
[TBL] [Abstract][Full Text] [Related]
45. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
[TBL] [Abstract][Full Text] [Related]
46. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.
Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J
J Leukoc Biol; 2010 Aug; 88(2):393-403. PubMed ID: 20466823
[TBL] [Abstract][Full Text] [Related]
47. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
48. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.
Odobasic D; Muljadi RC; O'Sullivan KM; Kettle AJ; Dickerhof N; Summers SA; Kitching AR; Holdsworth SR
Arthritis Rheumatol; 2015 Jul; 67(7):1868-80. PubMed ID: 25777776
[TBL] [Abstract][Full Text] [Related]
49. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
[TBL] [Abstract][Full Text] [Related]
50. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
51. Genetic proof for the transient nature of the Th17 phenotype.
Kurschus FC; Croxford AL; Heinen AP; Wörtge S; Ielo D; Waisman A
Eur J Immunol; 2010 Dec; 40(12):3336-46. PubMed ID: 21110317
[TBL] [Abstract][Full Text] [Related]
52. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis.
Tadema H; Abdulahad WH; Stegeman CA; Kallenberg CG; Heeringa P
PLoS One; 2011; 6(9):e24315. PubMed ID: 21915309
[TBL] [Abstract][Full Text] [Related]
54. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
[TBL] [Abstract][Full Text] [Related]
55. Methylprednisolone inhibits activated CD4+ T cell survival promoted by toll-like receptor ligands.
Lu YS; Pu LY; Li XC; Wang XH
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):376-83. PubMed ID: 20688601
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of ANCA-associated vasculitides.
Kallenberg CG
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
[TBL] [Abstract][Full Text] [Related]
57. Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis.
Brown HJ; Sacks SH; Robson MG
J Am Soc Nephrol; 2006 Jul; 17(7):1931-9. PubMed ID: 16738018
[TBL] [Abstract][Full Text] [Related]
58. Th1 polarization of CD4+ T cells by Toll-like receptor 3-activated human microglia.
Jack CS; Arbour N; Blain M; Meier UC; Prat A; Antel JP
J Neuropathol Exp Neurol; 2007 Sep; 66(9):848-59. PubMed ID: 17805015
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the renal CD4+ T-cell response in experimental autoimmune glomerulonephritis.
Hopfer H; Holzer J; Hünemörder S; Paust HJ; Sachs M; Meyer-Schwesinger C; Turner JE; Panzer U; Mittrücker HW
Kidney Int; 2012 Jul; 82(1):60-71. PubMed ID: 22437418
[TBL] [Abstract][Full Text] [Related]
60. Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: the role of interleukin-17 suppression?
Park SJ; Shin JI
Scand J Immunol; 2013 Mar; 77(3):221. PubMed ID: 23298391
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
